SCHEMBL17397958

SCHEMBL17397958

Cc1cnc(Nc2nc(Cl)ccc2S(=O)(=O)c2ccccc2)s1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ITK Q08881 1/20 0.46
▸ GSK3A P49840 1/20 0.45
▸ GSK3B P49841 1/20 0.45
▸ KDR P35968 1/20 0.41
▸ KMT2A Q03164 3/20 0.40
▸ PIP4K2C Q8TBX8 1/20 0.40
▸ NPC1 O15118 3/20 0.39
▸ RAB9A P51151 3/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ POLB P06746 1/20 0.39
▸ SMN1; SMN2 Q16637 4/20 0.39
▸ HTT P42858 2/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ PKM P14618 2/20 0.38
▸ HTR6 P50406 3/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ HTR1A P08908 1/20 0.37
▸ HTR2A P28223 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17398012 0.82 ALDH1A1 (0.48) KMT2ANPC1RAB9AMEN1SMN1; SMN2
SCHEMBL17397926 0.81 KDR (0.49) KDRHTTALDH1A1HPGDCDK7
SCHEMBL17398079 0.80 KMT2A (0.39) KMT2ANPC1RAB9AMEN1SMN1; SMN2
SCHEMBL17397982 0.79 ALDH1A1 (0.43) KDRKMT2ANPC1RAB9AMEN1
SCHEMBL17397920 0.78 ALDH1A1 (0.50) ITKKMT2ANPC1RAB9AMEN1
SCHEMBL17397956 0.77 ITK (0.64) ITKGSK3AGSK3BKDRKMT2A
SCHEMBL17398031 0.75 KDM4E (0.44) KMT2ANPC1RAB9AMEN1POLB
SCHEMBL17397918 0.74 ALDH1A1 (0.47) KMT2ANPC1RAB9AMEN1POLB
SCHEMBL17398026 0.73 ITK (0.48) ITKKMT2ANPC1RAB9AMEN1
SCHEMBL17398060 0.73 AURKA (0.46) GSK3AGSK3BKDRCDK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016001341-A1 SULFONYLAMINOPYRIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE F. HOFFMANN-LA ROCHE AG (CH) 2016-01-07 — — WO disclosed
Send feedback